Todd Steffes, Vice President, Healthcare Practice, FICO, explains how predictive modeling on medication adherence translates to better value and resource allocation in an industry where nonadherence costs more than $300 billion.
Mr. Steffes discusses how this decision-management company utilizes its own predictive analytic technology combined with third-party public data to evaluate an individual's medication adherence history over the period of 1 year. The data are then used to help healthcare stakeholders more efficienty utilize their resource allocation, spending more upfront time with at-risk patients and less with patients known to take their medicines as prescribed.
Balancing Life and Myeloma: A Patient-Centered Approach
November 22nd 2024In this second part of our discussion with Don M. Benson, MD, PhD, from our recent Institute for Value-Based Medicine® event in Cleveland, Ohio, he explains how his ultimate goal for his patients is for them to live as long and as well as possible.
Read More
Community Investment, Engagement Are Essential to Fully Address Cardiovascular Health Disparities
November 19th 2024Community-based researchers can teach clinicians a lot about how to best approach underserved populations disproportionately impacted by cardiovascular health complications.
Read More